These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 11697723)
1. ProC global: a new automated screening assay for the evaluation of total function of the protein C system. Dragoni F; Tormene D; Simioni P; Arcieri P; Avvisati G; Girolami A Clin Appl Thromb Hemost; 2001 Oct; 7(4):351-5. PubMed ID: 11697723 [TBL] [Abstract][Full Text] [Related]
2. Sensitivity of the ProC global assay for protein C pathway abnormalities. clinical experience in 899 unselected patients with venous thromboembolism. Toulon P; Adda R; Perez P Thromb Res; 2001 Oct; 104(2):93-103. PubMed ID: 11672753 [TBL] [Abstract][Full Text] [Related]
3. The reduced sensitivity of the ProC Global test in protein S deficient subjects reflects a reduction in the associated thrombotic risk. Gemmati D; Serino ML; Tognazzo S; Ongaro A; Moratelli S; Gilli G; Forini E; De Mattei M; Scapoli GL Blood Coagul Fibrinolysis; 2001 Dec; 12(8):691-7. PubMed ID: 11734670 [TBL] [Abstract][Full Text] [Related]
4. ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome. Heilmann L; von Tempelhoff GF; Pollow K Clin Appl Thromb Hemost; 2002 Oct; 8(4):319-24. PubMed ID: 12518722 [TBL] [Abstract][Full Text] [Related]
5. "ProC Global": a functional screening test that predicts recurrent venous thromboembolism. Grand'Maison A; Bates SM; Johnston M; McRae S; Ginsberg JS Thromb Haemost; 2005 Mar; 93(3):600-4. PubMed ID: 15735816 [TBL] [Abstract][Full Text] [Related]
6. An abnormal ProC Global test result is associated with an increased risk of venous thromboembolism independent of test sensitivity for protein C pathway abnormalities. Toulon P; Perez P; Rapp J; Adda R Thromb Haemost; 2007 Jul; 98(1):228-33. PubMed ID: 17598017 [TBL] [Abstract][Full Text] [Related]
7. Screening for risk factors for thrombosis using a new generation of assays developed to evaluate the functionality of the protein C anticoagulant pathway. Toulon P; Perez P Hematol Oncol Clin North Am; 2000 Apr; 14(2):379-89. PubMed ID: 10806561 [TBL] [Abstract][Full Text] [Related]
8. Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation. Toulon P; Halbmeyer WM; Hafner G; Schmitt Y; Randgard B; Odpadlik M; Van Den Eynden C; Wagner C Blood Coagul Fibrinolysis; 2000 Jul; 11(5):447-54. PubMed ID: 10937806 [TBL] [Abstract][Full Text] [Related]
9. An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. Gardiner C; Cooper PC; Makris M; Mackie IJ; Malia RG; Machin SJ Blood Coagul Fibrinolysis; 2002 Mar; 13(2):155-63. PubMed ID: 11914658 [TBL] [Abstract][Full Text] [Related]
10. ProC Global: the first functional screening assay for the complete protein C pathway. Dati F; Hafner G; Erbes H; Prellwitz W; Kraus M; Niemann F; Noah M; Wagner C Clin Chem; 1997 Sep; 43(9):1719-23. PubMed ID: 9299966 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy. Sarig G; Aberbach I; Schliamser L; Blumenfeld Z; Brenner B Thromb Haemost; 2006 Nov; 96(5):578-83. PubMed ID: 17080213 [TBL] [Abstract][Full Text] [Related]
12. Pro CR global: an effective screening test for thrombophilia. Gupta PK; Ahmed R; Kannan M; Dwivedi SN; Choudhry VP; Saxena R Am J Hematol; 2003 Nov; 74(3):208-10. PubMed ID: 14587054 [TBL] [Abstract][Full Text] [Related]
13. A modified functional global test to measure protein C, protein S activities and the activated protein C-resistance phenotype. Gemmati D; Serino ML; Scapoli GL Thromb Res; 1998 Nov; 92(3):141-8. PubMed ID: 9806366 [TBL] [Abstract][Full Text] [Related]
14. Economic impact of the introduction of the ProC Global assay in the screening strategy of protein C pathway abnormalities in unselected patients with a history of venous thromboembolism. Toulon P; Adda R; Perez P Thromb Haemost; 2001 Aug; 86(2):720-1. PubMed ID: 11522035 [No Abstract] [Full Text] [Related]
15. The ability of three global plasma assays to recognize thrombophilia. Andresen MS; Abildgaard U; Liestøl S; Sandset PM; Mowinckel MC; Ødegaard OR; Larsen ML; Diep LM Thromb Res; 2004; 113(6):411-7. PubMed ID: 15226097 [TBL] [Abstract][Full Text] [Related]
16. Modification of the ProC Global assay using dilution of patient plasma in factor V-depleted plasma as a screening assay for factor V Leiden mutation. Quincampoix JC; Legarff M; Rittling C; Andiva S; Toulon P Blood Coagul Fibrinolysis; 2001 Oct; 12(7):569-76. PubMed ID: 11685046 [TBL] [Abstract][Full Text] [Related]
17. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway. Robert A; Eschwège V; Hameg H; Drouet L; Aillaud MF Thromb Haemost; 1996 Apr; 75(4):562-6. PubMed ID: 8743179 [TBL] [Abstract][Full Text] [Related]
18. Protein C global assay in the evaluation of women with idiopathic pregnancy loss. Sarig G; Lanir N; Hoffman R; Brenner B Thromb Haemost; 2002 Jul; 88(1):32-6. PubMed ID: 12152673 [TBL] [Abstract][Full Text] [Related]
19. A new chromogenic assay (HemosIL ThromboPath) is sensitive to major prothrombotic risk factors affecting the protein C pathway. Results of a multicenter study. Toulon P; Smirnov M; Triscott M; Safa O; Biguzzi E; Bouziane K; Tripodi A Thromb Res; 2009 May; 124(1):137-43. PubMed ID: 19157524 [TBL] [Abstract][Full Text] [Related]
20. Prediction of recurrent venous thromboembolism by measuring ProC Global. Eichinger S; Hron G; Hirschl M; Bialonczyk C; Minar E; Kollars M; Kyrle PA Thromb Haemost; 2007 Dec; 98(6):1232-6. PubMed ID: 18064319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]